Radar · Women Health in United States
Best Women Health Companies in United States
The 360 best Women Health companies in United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: BillionToOne.
By Riya SenguptaFinancials
360companies tracked
$5.6Bdisclosed funding
1unicorns
188have raised
$5.6 billion in disclosed funding across 360 tracked companies tells you exactly how seriously the United States has started pricing Women Health as a capital category. This directory ranks those companies by equity funding and recent momentum, giving you a clear map of where conviction is concentrating.
The revenue picture is grounded. Eleven filers show a combined pool of roughly $185M, with a median of $6M and 14% YoY growth. But the outliers are what I find most telling: Auxilium Pharmaceuticals pulled $89M in revenue, fifteen times the sector median, with 34% YoY growth. Conceptus hit $34M (six times the median), Sequenom $29M (five times). Evofem, the most-funded name in our directory at $100M raised, changed hands in mid-2024, a reminder that big funding doesn't guarantee stable ownership. The global market sits at roughly $58B and is forecast to reach $65.2B by 2031 at a 5.4% CAGR, with sedentary lifestyles and irregular sleep cited as core demand drivers. So the structural tailwind is real. The question is which companies are actually converting it into durable revenue, not just rounds.
Sources & further reading
- ResearchAndMarkets.com
Ranked: Best Women Health companies in United States
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BillionToOne 🦄 Provider of cell-free cancer liquid biopsy test | $389M | 23 mo ago | 47 | Oguzhan Atay Co-Founder & CEO | WordPress Block EditorWordPressSentry+20 | 20 signals ▲150% Earnings · IPO · Leadership | 50 patents cfDNA methylation quantification and sequencing assay quality control for diagnostics | 1 launch · 1 partnership · 1 award |
| 2 | Gynesonics Developer of minimally invasive treatment for uterine fibroids | $283M | 31 mo ago | 92 | — | WordPressMySQLPHP+15 | — | 228 patents Image-guided needle-based ablation systems for uterine fibroid treatment | — |
| 3 | Sera Prognostics Developer of biomarker-based tests for pregnancy care | $258M | 62 mo ago | 123 123 → 80 (-35%) · sector median -20% | Gregory Critchfield CEO | — | — | 127 patents Predictive protein/biomarker assays for pregnancy timing and complications | — |
| 4 | Willow Wearable double electric breast pump kits | $228M | 29 mo ago | 109 | John Chang Co-Founder & Chief Technical Officer | Amazon WebstoreCart FunctionalityShopify+34 | — | 16 patents Patents concentrated in electrical & electronics | — |
| 5 | Biora Therapeutics Provider of non invasive prenatal genomic testing | $217M | 61 mo ago | 125 | Harry Stylli CEO and Chairman of the Board | — | — | — | — |
| 6 | TMRW Provider of an automated platform for patients and clinics to manage frozen eggs and embryos | $177M | 23 mo ago | 93 93 → 63 (-32%) · sector median -20% | Jeffrey Port Founder | — | — | — | — |
| 7 | Sprout Pharmaceuticals Developer of drugs for hypoactive sexual desire disorder in women | $175M | 18 mo ago | 31 | — | Cart FunctionalitySquarespace CommerceSquarespace+15 | — | — | — |
| 8 | Minerva Surgical Innovating minimally invasive solutions for women's uterine health and well-being | $170M | 40 mo ago | 155 155 → 93 (-40%) · sector median -20% | David Clapper CEO | WordPressMySQLPHP+36 | — | 217 patents Uterine tissue resection and extraction devices for minimally invasive endometrial procedures | — |
| 9 | Agile Therapeutics Developer of therapeutics for women healthcare | $124M | 28 mo ago | 19 | Al Altomari Chairman & CEO | — | — | 160 patents Personalized transdermal/dermal contraceptive drug delivery systems | — |
| 10 | Delphinus Medical Technologies Platform for breast ultrasound imaging | $114M | 26 mo ago | 48 | Neb Duric Co-Founder & Chief Technology Officer | ExpressionEngineApple iCloud MailSalesforce+23 | — | — | — |
| 11 | Comanche Developer of RNA therapeutics to treat preeclampsia | $111M | 29 mo ago | 17 | Mike Young Co-Founder & President | WordPressMySQLPHP+23 | — | — | — |
| 12 | Evofem Developer of sexual and reproductive health therapeutics 50Funding top 24%Product top 30%Moat top 38%Patents top 43% All 12 signals ▾Fundingtop 24% Producttop 30% Moattop 38% Patentstop 43% Fin. healthtop 46% Innovationtop 48% Markettop 49% Growthbottom 49% Talentbottom 49% Techbottom 43% Newsbottom 41% Globalbottom 40% Funding: Raised $100M across 15 rounds · 15 rounds over 17 yrs (0.9/yr) Product: 1 distinct product line · Company stage: Public rank vs industry peers · Fliar Intelligence Index 50/100 | $100M | 11 mo ago | 126 | Saundra Pelletier CEO ► Phexxi ► Solosec | WordPress Block EditorWordPressApple iCloud Mail+20 | 3 signals ▼79% Earnings · M&A | 60 patents Vaginal film drug delivery systems for contraception, STI prevention, and antimicrobial microbicides | 1 partnership |
| 13 | Aspira Women's Health Provider of diagnostic solution for ovarian malignancy in women 32Funding top 29%Tech top 46%Market bottom 46%Fin. health bottom 36% All 7 signals ▾Fundingtop 29% Techtop 46% Marketbottom 46% Fin. healthbottom 36% Growthbottom 35% Globalbottom 30% Newsbottom 21% Funding: Raised $96.7M across 8 rounds · 8 rounds over 16 yrs (0.5/yr) Tech: 36 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 32/100 | $97M | 9 mo ago | 85 85 → 60 (-29%) · sector median -20% | — | WordPressApple iCloud MailMySQL+25 | — | — | 2 partnerships |
| 14 | Mirvie Provider of non-invasive diagnostic tests for pregnant women 69Growth top 20%Funding top 21%Patents top 24%Talent top 28% All 9 signals ▾Growthtop 20% Fundingtop 21% Patentstop 24% Talenttop 28% Innovationtop 32% Moattop 36% Techtop 46% Globalbottom 40% Marketbottom 35% Growth: Headcount 23 → 35 (+52%) across vintages · Fresh capital in last 24 mo Funding: Raised $90.0M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 69/100 | $90M | 11 mo ago | 35 35 → 41 (+17%) · sector median -20% | Mads Melbye Co-Founder | WebflowReactTypekit+21 | — | 49 patents Non‑invasive prenatal diagnostics via methylation and RNA biomarkers for pregnancy monitoring | — |
| 15 | Viveve Medical Developer of therapy devices for women’s intimate health | $84M | 43 mo ago | 47 | — | — | — | — | — |
| 16 | Gameto Developer of therapeutics for the treatment of fertility and menopause | $83M | 10 mo ago | 35 | Dina Radenkovic Co-Founder & CEO | WordPressApple iCloud MailGoogle Workspace+24 | — | 27 patents In vitro ovarian/uterine organoid and gamete engineering for reproductive and stem‑cell applications | 1 expansion |
| 17 | Femasys Developer of medical device solutions for womens healthcare | $69M | 7 mo ago | 25 25 → 61 (+144%) · sector median -20% | Kathy Lee-Sepsick President & CEO (Founder) | Cart FunctionalityWordPressApple iCloud Mail+17 | 4 signals ▼60% Earnings · Contracts · Funding | 198 patents Medical imaging, drug delivery systems, and reproductive health devices. | 2 launchs |
| 18 | Materna Medical Provider of medical devices for women's pelvic health | $58M | 25 mo ago | 8 | Michael Stewart Co-Founder | — | — | — | — |
| 19 | Elucent Medical Wireless Brease Marker for Breast Cancer Treatment | $50M | 26 mo ago | 11 | Laura King Co-Founder & CEO | — | — | — | — |
| 20 | Daré Bioscience Developer of non-hormonal pharmaceutical products for female contraceptives 50Funding top 27%Product top 28%Growth top 37%Innovation top 38% All 11 signals ▾Fundingtop 27% Producttop 28% Growthtop 37% Innovationtop 38% Techtop 40% Moattop 48% Talentbottom 49% Newsbottom 45% Fin. healthbottom 43% Marketbottom 33% Globalbottom 32% Funding: Raised $39.7M across 17 rounds · 17 rounds over 9 yrs (1.9/yr) Product: 3 distinct product lines · 1 published app (300 installs) rank vs industry peers · Fliar Intelligence Index 50/100 | $40M | 6 mo ago | 30 30 → 27 (-10%) · sector median -20% | Sabrina Johnson President and CEO | WordPressMySQLPHP+24 | 3 signals ▼25% Earnings | — | 4 launchs |
| 21 | Overture Life Developer of embryology diagnosis device for professionals 67Patents top 26%AI top 28%Talent top 28%Funding top 29% All 11 signals ▾Patentstop 26% AItop 28% Talenttop 28% Fundingtop 29% Moattop 31% Innovationtop 32% Growthtop 35% Techbottom 44% Globalbottom 43% Marketbottom 37% Newsbottom 18% Patents: 44 patents matched (strict assignee match) · 34 filings since 2022 vs 10 in 2017-21 AI: Holds AI/ML patents (G06N-family CPC) · Product described with: ai powered rank vs industry peers · Fliar Intelligence Index 67/100 | $37M | 7 mo ago | 41 | Jose Horcajadas Co-Founder & Chief Scientific Officer | ReactReact RouterAmazon Web Services+11 | — | 44 patents Automated microinjection and microfluidic handling for IVF and embryo selection | 1 launch · 1 partnership |
| 22 | Movano Health Developer of radio frequency-enabled health monitoring devices and wearable technology | $30M | 26 mo ago | 27 | John Mastrototaro CEO | WordPressMySQLPHP+16 | — | — | — |
| 23 | Novocuff Developer of medical device to prevent infant mortality caused by preterm birth complications | $28M | 24 mo ago | 4 | Amelia Degenkolb Co-Founder & CEO | — | — | 18 patents Obstetric cervical control devices for managing labor and preventing preterm birth | — |
| 24 | Raydiant Oximetry Developer of noninvasive sensor technology for fetal oxygen level monitoring | $26M | 24 mo ago | 24 | Neil Ray Founder & CEO | — | — | 97 patents Non-invasive fetal and uterine oxygenation monitoring using trans-abdominal optical sensors | — |
| 25 | BioIncept Biotechnology firm pioneering regenerative medicine, immune modulation, and reproductive health solutions | $17M | 13 mo ago | — | Jacqueline Barnea Co-Founder & CEO | — | — | 153 patents Peptide therapeutics and biomarker diagnostics for neurodegeneration, liver disease, and embryo viability | — |
| 26 | Cerene Provider of an endometrial ablation treatment for menorrhagia | $15M | 27 mo ago | 26 26 → 41 (+58%) · sector median -20% | Ric Cote President and CEO | Cart FunctionalitySquarespace CommerceSquarespace+20 | — | — | 1 expansion |
| 27 | Granata Bio Developer of therapeutics for women's health and infertility | $14M | 13 mo ago | — | Marc Chung Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+14 | — | — | — |
| 28 | AutoIVF Developer of solutions to automate and improve In Vitro Fertilization procedures | $12M | 13 mo ago | 4 | Mitchel Sayare Co-Founder & Chairman | — | — | 2 patents Patents concentrated in transport & manufacturing processes | — |
| 29 | Emulait Internet first brand offering breastfeeding bottles 40AI top 15%Tech top 29%Growth top 35%Talent top 38% All 12 signals ▾AItop 15% Techtop 29% Growthtop 35% Talenttop 38% Moattop 41% Fundingtop 50% Productbottom 48% Patentsbottom 39% Innovationbottom 30% Globalbottom 29% Marketbottom 25% Customersbottom 6% AI: Holds AI/ML patents (G06N-family CPC) Tech: 46 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 40/100 | $11M | 10 mo ago | 11 | Bob Worrell Co-Founder | Cart FunctionalityShopifySentry+38 | — | 2 patents Patents concentrated in computing, sensing & instrumentation | — |
| 30 | Flyte Developer of an at-home intravaginal device for treating stress urinary incontinence | $10M | 14 mo ago | 3 | — | Cart FunctionalityShopifyYouTube+28 | 5 signals Announcements · Acquisition · M&A | 18 patents Magnetic levitation-based interactive displays and levitating lighting devices | — |
| 31 | Reia Developer of non-surgical device for pelvic prolapse | $9M | 13 mo ago | 7 | Paul Hanissian Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+19 | — | 23 patents Gynecologic pessary devices and applicators for pelvic organ prolapse treatment | — |
| 32 | CairnSurgical Developer of 3D printed surgical guides for breast cancer treatment | $8M | 21 mo ago | — | Venkat Krishnaswamy Co-Founder and Chief Technology Officer | — | — | 18 patents Surgical guidance and imaging support devices for precise tissue removal procedures | — |
| 33 | Expanse Bio Developer of ex vivo systems for long-term ovarian assessment | $8M | 9 mo ago | — | Bradley Weegman CEO | — | — | — | — |
| 34 | Advanced Tactile Imaging Innovating women's pelvic healthcare with biomechanical mapping and digital twin technologies 16Innovation top 40%Funding top 43%Talent bottom 45%Product bottom 44% All 7 signals ▾Innovationtop 40% Fundingtop 43% Talentbottom 45% Productbottom 44% Globalbottom 29% Techbottom 24% Marketbottom 13% Innovation: 2 product lines Funding: Raised $6.3M across 8 rounds · 8 rounds over 10 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 16/100 | $6M | 10 mo ago | 6 | Vladimir Egorov Chairman and Chief Executive Officer | — | — | — | — |
| 35 | KOKO Medical Developer of medical device to address postpartum hemorrhage of women | $6M | 4 mo ago | 10 | Skott Greenhalgh Co-Founder & CEO | — | — | — | — |
| 36 | MilkMate Developer of breast pumping solution for workplace wellness rooms | $5M | 17 mo ago | 5 | Patrice Meagher Founder & CEO | — | — | — | 1 partnership |
| 37 | Ceek Womens Health Innovative women's health solutions for comfortable gynecological exams and procedures | $5M | 16 mo ago | 26 | Fahti Khosrowshahi Founder & CEO | Cart FunctionalityShopifyShop Pay+17 | — | — | 4 launchs |
| 38 | kegg Manufacturer of medical devices for tracking cervical mucus fertility metrics | $4M | 17 mo ago | 6 | Kristina Cahojova Founder & CEO | Cart FunctionalityShopifyShop Pay+29 | — | — | 1 expansion |
| 39 | Madorra Provider of a therapeutic device for the treatment of vaginal atrophy and dryness | $4M | 21 mo ago | 6 | Holly Rockweiler Co-Founder & CEO | — | — | 22 patents Medical ultrasound systems for vulvovaginal aesthetic rejuvenation procedures | — |
| 40 | Imagine Scientific Manufacturer of device for breast cancer diagnostic | $4M | 13 mo ago | — | Eric Silver CEO | — | — | — | — |
| 41 | Nfant Developer of infant feeding monitoring device | $3M | 11 mo ago | 7 | — | WordPress Block EditorCart FunctionalityWordPress+36 | — | 20 patents Lactation measurement devices and oral motor strength assessment technologies | — |
| 42 | Hera Biotech Developer of diagnostic test kit for endometriosis | $2M | 9 mo ago | 5 | Bruce Nicholson Co-Founder | JoomlaPHPCentOS+13 | — | — | — |
| 43 | Bexa Provider of a device for breast examination in women | $2M | 18 mo ago | — | Joe Peterson CEO | WordPressZohoMySQL+21 | — | — | — |
| 44 | Storx Technologies Developer of a non-invasive fetal monitoring device | $1M | 13 mo ago | 3 | Soheil Ghiasi Co-Founder | — | — | — | — |
| 45 | Venova Technologies Developer of a novel, hormone-free, copper-free birth control device | $983K | 17 mo ago | — | Liz Earley Co-Founder & COO & CFO | — | — | — | — |
| 46 | Gynion Developer of therapeutic devices for women health applications | $969K | 13 mo ago | 2 | Steven Goldstein Co-Founder & Chief Medical Officer | — | — | 14 patents Intrauterine drug delivery systems for localized therapeutic agent administration. | — |
| 47 | Moremme Developer of hormone-free, natural vaginal health products | $870K | 15 mo ago | — | Ore Adedoyin Co-Founder | — | — | — | — |
| 48 | Latde Diagnostics Developer of diagnostic test for urinary tract infections | $349K | 14 mo ago | 3 | Sloan Siegrist Co-Founder & CSO | — | — | — | — |
| 49 | Avana Health Developer of treatments for women health | $128K | 8 mo ago | 6 | Peter Pacult Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+10 | — | — | — |
| 50 | iSono Health Provider of AI-based 3D wearable device for early breast cancer detection | $120K | 8 mo ago | 10 | Neda Razavi CEO | — | — | — | — |
Top 12 Women Health companies in United States
#1
Public · Atlanta, Georgia · founded 2004 · 25 employees$69.2Mraised▾
Public · Atlanta, Georgia · founded 2004 · 25 employees
Developer of medical device solutions for womens healthcare. Its products include FemVue Saline-Air Device, which creates and delivers an alternating pattern of saline and air as a continuous stream, and enables physicians to assess their patients’ fallopian tubes; and FemChec Pressure Management Device, which limits the maximum applied pressure while performing hysterosalpingogram. It offers FemCerv, an endocervical curettage device to collect a non-contaminated tissue sample for cervical cancer screening.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 9k LinkedIn followers — 4.7% of this cohort's audience
Activity: 2 product launches announced in 12 mo
Funding rounds
- Nov 2025Post IPO$8M
- Jun 2025Post IPO$1.4M
- Nov 2023Post IPO$6.8M
- Jan 2017Series C$4M
Founders & team
Investors
Legacy Capital, Salem Partners, PharmaCyte Biotech, Percy Capital
Tech stack
Apple Icloud MailCart FunctionalityCloudflareCloudflare Rocket LoaderCore-JsElementor
#2
Public · Austin, Texas · founded 1993 · 85 employees$96.7Mraised▾
Public · Austin, Texas · founded 1993 · 85 employees
Provider of diagnostic solution for ovarian malignancy in women. It offers products OVA1 and OVERA to detect the risk of ovarian cancer for patients. It also offers its flagship product for the detection of risk heredity breast and ovary cancer; ASPiRA GenetiXSM testing which offers comprehensive genetic testing options with a gynecologic focus.
Fliar Intelligence Index™ 32how this company ranks against its industry peers
Funding
top 29%Tech
top 46%Market
bottom 46%Fin. health
bottom 36%Growth
bottom 35%Global
bottom 30%Funding: Raised $96.7M across 8 rounds · 8 rounds over 16 yrs (0.5/yr) · Last round Post IPO (Sep 2025)
Tech: 36 technologies across 4/8 capability areas · Cloud: Cloudflare · Security: Hsts
Market: 85 employees (top 40% of Genomics) · Revenue ~$9.2M · Top-10,000,000 web property
Audience (LinkedIn): 6k LinkedIn followers — 3.3% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. Chelton Clinic) announced in 12 mo
Funding rounds
- Sep 2025Post IPO$3M
- Mar 2025Post IPO$1.4M
- Jun 2024Post IPO$1.9M
- Jul 2020Post IPO$11M
Tech stack
Apple Icloud MailBeaver BuilderCloudflareCore-JsDocusignFacebook Login
#3
Public · San Diego, California · founded 2005 · 30 employees$39.7Mraised▾
Public · San Diego, California · founded 2005 · 30 employees
DARE BIOSCIENCE is a developer of non-hormonal pharmaceutical products for female contraceptives. Their lead candidate, Ovaprene, is an intravaginal non-hormonal ring, that can provide contraceptive protection over several weeks. The design of the ring has a permeable mesh in the centre of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The spermiostatic agents are ascorbic acid and ferrous gluconate, which create pH buffering and immobilization of sperm.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 27%Product
top 28%Growth
top 37%Innovation
top 38%Tech
top 40%Moat
top 48%Funding: Raised $39.7M across 17 rounds · 17 rounds over 9 yrs (1.9/yr) · Last round Grant (prize money) (Nov 2025)
Product: 3 distinct product lines · 1 published app (300 installs) · Company stage: Public
Growth: Headcount 28 → 30 (+7%) across vintages · Revenue +10429% YoY · Web rank 50,000,000 → 5,000,000 YoY
Audience (LinkedIn): 6k LinkedIn followers — 3.3% of this cohort's audience
Activity (LinkedIn): 4 product launches announced in 12 mo
Funding rounds
- Nov 2025Grant (prize money)$3.6M
- Feb 2025Grant (prize money)$2.3M
- Dec 2024Grant (prize money)$1M
- Jan 2024Grant (prize money)$750K
Founders & team
Investors
NICHD, Gates, NIH, HHS
Tech stack
Acquia Cloud PlatformAcquia Cloud Site FactoryAdobe AnalyticsAdobe Experience Platform Identity ServiceAdobe Experience Platform LaunchAmazon Web Services
#4
Series C · Palo Alto, California · founded 2017 · 41 employees$37Mraised▾
Series C · Palo Alto, California · founded 2017 · 41 employees
Developer of embryology diagnosis device for professionals. It offers DaVitri an automated platform designed to modernize egg freezing and embryo warming workflows, automates critical timing and cryoprotectant exposure steps for improved consistency and oocyte survival rates. It also offers m|z test an AI powered metabolomic test designed for non-invasive embryo selection.
Fliar Intelligence Index™ 67how this company ranks against its industry peers
Patents
top 26%AI
top 28%Talent
top 28%Funding
top 29%Moat
top 31%Innovation
top 32%Patents: 44 patents matched (strict assignee match) · 34 filings since 2022 vs 10 in 2017-21 · Latest publication 2026
AI: Holds AI/ML patents (G06N-family CPC) · Product described with: ai powered
Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
Audience (LinkedIn): 12k LinkedIn followers — 6.2% of this cohort's audience
Activity (LinkedIn): 1 product launches · 1 partnerships (incl. TekServis Ltd. ti.) announced in 12 mo
Funding rounds
- Nov 2025Conventional Debt$23M
- Apr 2025Series C$20.6M
- May 2021Series B$15M
- Dec 2018Series A$13.6M
Founders & team
Investors
Octopus Ventures, Google Ventures, Khosla Ventures, Felicis Ventures, Overwater Ventures, European Investment Bank
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesCdnjsCloudflareCloudflare Bot Management
#5
Public · San Diego, California · founded 2009 · 126 employees$100Mraised▾
Public · San Diego, California · founded 2009 · 126 employees
Developer of sexual and reproductive health therapeutics. It offers two drug products which include PHEXXI vaginal gel that provides women with an in-the-moment contraceptive that maintains the baseline vaginal pH environment and SOLOSEC (secnidazole) which is used to treat bacterial vaginosis in women and the STI trichomoniasis in both men and women.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 24%Product
top 30%Moat
top 38%Patents
top 43%Fin. health
top 46%Innovation
top 48%Funding: Raised $100M across 15 rounds · 15 rounds over 17 yrs (0.9/yr) · Last round Post IPO (Jun 2025)
Product: 1 distinct product line · Company stage: Public
Moat: Editorial + unicorn rating 5/10 · IP moat: 60 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 10k LinkedIn followers — 5.5% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. Clavi Davis Pharmaceuticals) announced in 12 mo
Funding rounds
- Jun 2025Post IPO$925K
- Apr 2025Post IPO$750K
- Sep 2023Post IPO$2.9M
- Feb 2023Post IPO$1.4M
Founders & team
Investors
Woodford Investment Management, Invesco Mutual Fund, Adjuvant Capital, Keystone Capital, Walleye, Pinz Capital Management
#6
Series C · United States · founded 2020 · 35 employees$83Mraised▾
Series C · United States · founded 2020 · 35 employees
Developer of therapeutics for the treatment of fertility and menopause. It offers Fertilo an investigational fertility therapy that uses engineered ovarian support cells derived from induced pluripotent stem cells. It also offers Deovo an in vitro organoid model of the female reproductive system to develop drugs for ovarian cancer.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 22k LinkedIn followers — 11.4% of this cohort's audience · 33 engagements/post (1.9× cohort median)
Activity: 1 expansions announced in 12 mo
Funding rounds
- Jul 2025Series C$44M
- May 2024Series B$43M
- Sep 2022Series A$17M
- Jan 2022Series A$20M
Founders & team
Investors
Two Sigma Ventures, RA Capital Management, Insight Partners, Future Ventures, Bold Capital Partners, Ingeborg Investments
Tech stack
All In One SeoAmazon Web ServicesApple Icloud MailComplianzCore-JsElementor
#7
Series B · San Francisco, California · founded 2019 · 35 employees$90Mraised▾
Series B · San Francisco, California · founded 2019 · 35 employees
Provider of non-invasive diagnostic tests for pregnant women. The company offers blood test-based diagnostics to predict the fetal development and health conditions of prenatal babies. They perform the detection of nine cell-free RNA (cfRNA) which help in measuring the gestational age of the fetal. The other non-invasive tests in which the maternal blood is analyzed for the cRNA to detect the preterm risk management solutions(advance of labor) in women.
Fliar Intelligence Index™ 69how this company ranks against its industry peers
Growth
top 20%Funding
top 21%Patents
top 24%Talent
top 28%Innovation
top 32%Moat
top 36%Growth: Headcount 23 → 35 (+52%) across vintages · Fresh capital in last 24 mo
Funding: Raised $90.0M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) · Last round Series B (Jul 2025)
Patents: 49 patents matched (strict assignee match) · 41 filings since 2022 vs 8 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 5k LinkedIn followers — 2.9% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public)
Activity (LinkedIn): 2 awards announced in 12 mo
Funding rounds
- Jul 2025Series B$23.7M
- Aug 2023Grant (prize money)$4.6M
- May 2022Conventional Debt—
- May 2022Series B$60M
Founders & team
Investors
Comerica, Decheng Capital, BlackRock, Foresite Capital, General Catalyst, Google Ventures
#8
Series B · Malvern, Pennsylvania · founded 2019 · 10 employees$6Mraised▾
Series B · Malvern, Pennsylvania · founded 2019 · 10 employees
Developer of medical device to address postpartum hemorrhage of women. It offers KOKO device, is a catheter-based technology to encourage uterine contractions while removing excess blood to stop postpartum hemorrhaging.
Funding rounds
- Feb 2026Series B$8M
- Dec 2023Series A$6M
- Nov 2021Seed$2.5M
Founders & team
#9
Acquired · Raleigh, North Carolina · founded 2011 · 31 employees$174.6Mraised▾
Acquired · Raleigh, North Carolina · founded 2011 · 31 employees
Sprout Pharmaceuticals has developed drugs for women's health. The company has developed an FDA-approved non-hormonal pill called ADDYI to cure Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Funding rounds
- Dec 2024Series D$10.6M
- Apr 2023Series D$7.1M
- Aug 2022Series D$28M
- May 2022Series D$25.1M
Investors
New Ventures Funds, Lunsford Capital, Scientia Ventures
Tech stack
AngularCart FunctionalityCore-JsGodaddyGoogle AnalyticsGoogle Font Api
#10
Public · San Francisco, California · founded 2015 · 47 employees$388.6Mraised▾
Public · San Francisco, California · founded 2015 · 47 employees
Provider of cell-free cancer liquid biopsy test. The company provides a molecular counter platform to count the DNA molecules from blood samples. It provides genetic tests for cystic fibrosis, spinal muscular atrophy, sickle cell disease, etc.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 42k LinkedIn followers — 22.3% of this cohort's audience
Activity: 1 product launches · 1 partnerships · 1 awards (incl. four largest commercial insurers in the U.S.) announced in 12 mo
Funding rounds
- Jun 2024Series D$130M
- Dec 2022Conventional Debt—
- Dec 2022Series C$48.5M
- Mar 2022Series C$125M
Founders & team
Investors
500 Global, Hummingbird Ventures, Neotribe, Libertus Capital, Pacific 8 Ventures, Y Combinator
Tech stack
Apple Icloud MailCdnjsCloudflareCookieyesGoogle AnalyticsGoogle Font Api
#11
Funding Raised · North Charleston, South Carolina · founded 2022$7.6Mraised▾
Funding Raised · North Charleston, South Carolina · founded 2022
Developer of ex vivo systems for long-term ovarian assessment. The company focuses on creating an ex vivo system for the assessment of ovarian damage at morphological, functional, and molecular levels in a whole ovary model.
Funding rounds
- Aug 2025Grant (prize money)$309.3K
- Oct 2023Grant (prize money)$2.5M
- Sep 2023Grant (prize money)$309.3K
- Aug 2019Grant (prize money)$2M
Founders & team
Investors
HHS
#12
Series D · New York City, New York · founded 2014 · 93 employees$176.9Mraised▾
Series D · New York City, New York · founded 2014 · 93 employees
Provider of an automated platform for patients and clinics to manage frozen eggs and embryos. It provides an automated robotic platform to store eggs and embryos and enables patients and clinics to be tracked and managed remotely.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers — 7.2% of this cohort's audience
Funding rounds
- Jun 2024Series D$28.2M
- Dec 2022Angel—
- Apr 2022Conventional Debt$5M
- Jul 2021Conventional Debt—
Founders & team
Investors
5AM Ventures, F Capital Partners, Transformation Capital, Casdin Capital, Google Ventures, Special Situations Fund
Funding & investor landscape
$5.6Btotal disclosed funding
189companies funded
752disclosed rounds
0rounds last 90 days
Most active investors
New Enterprise Associates7 rounds
Y Combinator6 rounds
Notable founders
Kathy Lee-Sepsick
President & CEO (Founder) · Femasys
Sabrina Johnson
President and CEO · Daré Bioscience
Jose Horcajadas
Co-Founder & Chief Scientific Officer · Overture Life
Santiago Munne
Co-Founder & CIO · Overture Life
Saundra Pelletier
CEO ► Phexxi ► Solosec · Evofem
Dina Radenkovic
Co-Founder & CEO · Gameto
Martin Varsavsky
Co-Founder · Gameto
Mads Melbye
Co-Founder · Mirvie
Maneesh Jain
Co-Founder & CEO · Mirvie
Skott Greenhalgh
Co-Founder & CEO · KOKO Medical
Jason Keiser
Co-Founder & VP of Operations · KOKO Medical
Oguzhan Atay
Co-Founder & CEO · BillionToOne
Prism market signals · United States · country-scoped Prism corpus, 15,258,404 docs
Market landscape — 10 sub-themes by coverage
Share of Women Health coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
How many Women Health companies are there in United States?
Radar tracks 360 indexable Women Health companies headquartered in United States that meet our profile-completeness bar.
What is the total funding raised by Women Health companies in United States?
The Women Health companies in United States on this list have raised a combined $5.6B in disclosed equity funding across 189 funded companies.
Which is the highest-funded Women Health company in United States?
BillionToOne is the highest-funded Women Health company in United States, with $388.6M in disclosed equity funding.
How many Women Health companies in United States are funded?
189 of the 360 Women Health companies in United States on this list have disclosed at least one equity funding round.
How many Women Health unicorns are there in United States?
1 Women Health company in United States on this list is valued at $1B or more.
Who are the top investors in United States Women Health companies?
The most active investors in United States Women Health companies on this list include HHS, National Science Foundation, New Enterprise Associates, Orbimed, Y Combinator.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.